LONDON (Reuters) – New highly-effective weight loss drugs such as Novo Nordisk’s Wegovy are not a “silver bullet” for addressing the rapid rise in global obesity rates, the World Health Organization’s nutrition chief told Reuters, as the agency conducts its first review of obesity management guidelines in more than 20 years. Read full story
Exclusive-Wegovy, other weight loss drugs ‘no silver bullet’, says WHO amid obesity review
